These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21883147)

  • 1. Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice.
    Bashashati M; Storr MA; Nikas SP; Wood JT; Godlewski G; Liu J; Ho W; Keenan CM; Zhang H; Alapafuja SO; Cravatt BF; Lutz B; Mackie K; Kunos G; Patel KD; Makriyannis A; Davison JS; Sharkey KA
    Br J Pharmacol; 2012 Mar; 165(5):1556-71. PubMed ID: 21883147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides.
    Fichna J; Sałaga M; Stuart J; Saur D; Sobczak M; Zatorski H; Timmermans JP; Bradshaw HB; Ahn K; Storr MA
    Neurogastroenterol Motil; 2014 Apr; 26(4):470-81. PubMed ID: 24460851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for both inverse agonism at the cannabinoid CB1 receptor and the lack of an endogenous cannabinoid tone in the rat and guinea-pig isolated ileum myenteric plexus-longitudinal muscle preparation.
    Makwana R; Molleman A; Parsons ME
    Br J Pharmacol; 2010 Jun; 160(3):615-26. PubMed ID: 20590566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase.
    de Filippis D; Iuvone T; d'amico A; Esposito G; Steardo L; Herman AG; Pelckmans PA; de Winter BY; de Man JG
    Neurogastroenterol Motil; 2008 Aug; 20(8):919-27. PubMed ID: 18373655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.
    Booker L; Kinsey SG; Abdullah RA; Blankman JL; Long JZ; Ezzili C; Boger DL; Cravatt BF; Lichtman AH
    Br J Pharmacol; 2012 Apr; 165(8):2485-96. PubMed ID: 21506952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects.
    Godlewski G; Alapafuja SO; Bátkai S; Nikas SP; Cinar R; Offertáler L; Osei-Hyiaman D; Liu J; Mukhopadhyay B; Harvey-White J; Tam J; Pacak K; Blankman JL; Cravatt BF; Makriyannis A; Kunos G
    Chem Biol; 2010 Nov; 17(11):1256-66. PubMed ID: 21095576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of CB(1) neutral antagonists and inverse agonists on gastrointestinal motility in mice.
    Storr MA; Bashashati M; Hirota C; Vemuri VK; Keenan CM; Duncan M; Lutz B; Mackie K; Makriyannis A; Macnaughton WK; Sharkey KA
    Neurogastroenterol Motil; 2010 Jul; 22(7):787-96, e223. PubMed ID: 20180825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice.
    Izzo AA; Capasso R; Aviello G; Borrelli F; Romano B; Piscitelli F; Gallo L; Capasso F; Orlando P; Di Marzo V
    Br J Pharmacol; 2012 Jun; 166(4):1444-60. PubMed ID: 22300105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice.
    Cluny NL; Keenan CM; Duncan M; Fox A; Lutz B; Sharkey KA
    J Pharmacol Exp Ther; 2010 Sep; 334(3):973-80. PubMed ID: 20571060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors.
    Benito C; Tolón RM; Castillo AI; Ruiz-Valdepeñas L; Martínez-Orgado JA; Fernández-Sánchez FJ; Vázquez C; Cravatt BF; Romero J
    Br J Pharmacol; 2012 Jun; 166(4):1474-89. PubMed ID: 22321194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats.
    Duncan M; Mouihate A; Mackie K; Keenan CM; Buckley NE; Davison JS; Patel KD; Pittman QJ; Sharkey KA
    Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G78-G87. PubMed ID: 18483180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice.
    Li K; Fichna J; Schicho R; Saur D; Bashashati M; Mackie K; Li Y; Zimmer A; Göke B; Sharkey KA; Storr M
    Neuropharmacology; 2013 Aug; 71(100):255-63. PubMed ID: 23603203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel derivatives of 1,2,3-triazole, cannabinoid-1 receptor ligands modulate gastrointestinal motility in mice.
    Szymaszkiewicz A; Zielinska M; Li K; Ramanathan M; Alam S; Hou DR; Fichna J; Storr M
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Apr; 391(4):435-444. PubMed ID: 29404698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice.
    Capasso R; Borrelli F; Aviello G; Romano B; Scalisi C; Capasso F; Izzo AA
    Br J Pharmacol; 2008 Jul; 154(5):1001-8. PubMed ID: 18469842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice.
    Ramesh D; Ross GR; Schlosburg JE; Owens RA; Abdullah RA; Kinsey SG; Long JZ; Nomura DK; Sim-Selley LJ; Cravatt BF; Akbarali HI; Lichtman AH
    J Pharmacol Exp Ther; 2011 Oct; 339(1):173-85. PubMed ID: 21719468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.
    Naidu PS; Booker L; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2009 Apr; 329(1):48-56. PubMed ID: 19118134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner.
    Keenan CM; Storr MA; Thakur GA; Wood JT; Wager-Miller J; Straiker A; Eno MR; Nikas SP; Bashashati M; Hu H; Mackie K; Makriyannis A; Sharkey KA
    Br J Pharmacol; 2015 May; 172(9):2406-18. PubMed ID: 25572435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT).
    Bashashati M; Fichna J; Piscitelli F; Capasso R; Izzo AA; Sibaev A; Timmermans JP; Cenac N; Vergnolle N; Di Marzo V; Storr M
    Neurogastroenterol Motil; 2017 Dec; 29(12):. PubMed ID: 28695708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines.
    Brown I; Cascio MG; Wahle KW; Smoum R; Mechoulam R; Ross RA; Pertwee RG; Heys SD
    Carcinogenesis; 2010 Sep; 31(9):1584-91. PubMed ID: 20660502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.